loadpatents
name:-0.050443887710571
name:-0.0096471309661865
name:-0.010170936584473
Je Il Pharmaceutical Co., Ltd. Patent Filings

Je Il Pharmaceutical Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Je Il Pharmaceutical Co., Ltd..The latest application filed is for "c-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same".

Company Profile
2.7.7
  • Je Il Pharmaceutical Co., Ltd. - Seoul KR
  • JE IL Pharmaceutical CO., LTD. - 745-4 Banpo-1 dong, Seocho-gu Seoul KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
Grant 10,464,919 - Lee , et al. No
2019-11-05
C-Glucoside Derivative Containing Fused Phenyl Ring or Pharmaceutically Acceptable Salt Thereof, Process for Preparing Same, and Pharmaceutical Composition Comprising Same
App 20190002425 - Nam; Joon Woo ;   et al.
2019-01-03
Tricyclic Derivative Compound, Method for Preparing Same, and Pharmaceutical Composition Comprising Same
App 20180162834 - Lee; Hyunho ;   et al.
2018-06-14
Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
Grant 8,815,891 - Kim , et al. August 26, 2
2014-08-26
Method for preparing tricyclic derivatives
Grant 8,742,160 - Kim , et al. June 3, 2
2014-06-03
Efficient generation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells
Grant 8,492,149 - Cho , et al. July 23, 2
2013-07-23
{4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component
Grant 8,334,277 - Kang , et al. December 18, 2
2012-12-18
Method For Preparing Tricyclic Derivatives
App 20120101296 - Kim; Myung-Hwa ;   et al.
2012-04-26
Novel Tricyclic Derivative Or Pharmaceutically Acceptable Salts Thereof, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same
App 20110218193 - Kim; Myung-Hwa ;   et al.
2011-09-08
Novel Phosphate Or A Pharmaceutically Acceptable Salt Thereof, A Production Method Therefor And A Pharmaceutical Composition For Preventing And Treating Central Nervous System Disorders Containing The Same As An Active Component
App 20110059923 - Kang; Seok Won ;   et al.
2011-03-10
Efficient Generation Of Neural Progenitors, Neurons, And Dopaminergic Neurons From Human Embryonic Stem Cells
App 20100317103 - Cho; Myung Soo ;   et al.
2010-12-16
Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
App 20070179143 - Kim; Myung-Hwa ;   et al.
2007-08-02
Memory enhancing and anti-dementia agent containing dehydroevodiamine HC1 as active ingredient
Grant 5,859,016 - Suh , et al. January 12, 1
1999-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed